KILIÇKAP, S. Et Al. 2019. Is There Any Prognostic Significance in Pleural Involvement and/or Effusion (Ple-I/E) in Patients With ALK-positive NSCLC?. ESMO (European Society for Medical Oncology) 2019 Congress , (Barcelona, Spain).

KILIÇKAP, S., BUĞDAYCI BAŞOL, F., DEMİRKAZIK, A., GÜRSOY, P., DEMİRCİ, U., ERMAN, M., ... YUMUK, P. F.(2019). Is There Any Prognostic Significance in Pleural Involvement and/or Effusion (Ple-I/E) in Patients With ALK-positive NSCLC? . ESMO (European Society for Medical Oncology) 2019 Congress, Barcelona, Spain

KILIÇKAP, SAADETTİN Et Al. "Is There Any Prognostic Significance in Pleural Involvement and/or Effusion (Ple-I/E) in Patients With ALK-positive NSCLC?," ESMO (European Society for Medical Oncology) 2019 Congress, Barcelona, Spain, 2019

KILIÇKAP, SAADETTİN Et Al. "Is There Any Prognostic Significance in Pleural Involvement and/or Effusion (Ple-I/E) in Patients With ALK-positive NSCLC?." ESMO (European Society for Medical Oncology) 2019 Congress , Barcelona, Spain, 2019

KILIÇKAP, S. Et Al. (2019) . "Is There Any Prognostic Significance in Pleural Involvement and/or Effusion (Ple-I/E) in Patients With ALK-positive NSCLC?." ESMO (European Society for Medical Oncology) 2019 Congress , Barcelona, Spain.

@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={Is There Any Prognostic Significance in Pleural Involvement and/or Effusion (Ple-I/E) in Patients With ALK-positive NSCLC?}, congress name={ESMO (European Society for Medical Oncology) 2019 Congress}, city={Barcelona}, country={Spain}, year={2019}}